Annual revenue rose from KRW 396 million in 2022 to KRW 696 million in 2023 (up 75.7% year on year) and KRW 825 million in 2024 (up 18.6%), then reached KRW 23.8 billion in 2025 (up 2,790.3%), growing for three consecutive years from 2023 through 2025.
Within the 2022 to 2025 span, 2025 was the largest year and 2022 the smallest. Related sources attribute the 2025 jump to wholesale sales added through the merger and growth in cosmetics.
Operating losses were KRW 12.6 billion in 2022 and widened to KRW 13 billion in 2023, then narrowed to KRW 11.3 billion in 2024 and KRW 4.53 billion in 2025, with losses in all four years. The same sources cite higher R&D spending and one-off costs as the background to the 2025 operating loss.
The operating margin improved from -3,176.6% in 2022 to -1,868.3% in 2023, -1,371.0% in 2024 and -19.0% in 2025. Net losses attributable to controlling shareholders were KRW 22.9 billion in 2022, KRW 24 billion in 2023 and KRW 12.4 billion in 2024, before a return to profit in 2025 with net income of KRW 203 million.
Press reports describe a bargain-purchase gain of about KRW 1.8 billion recognized in the 2025 accounts, so part of the 2025 profit is one-off.
Equity totaled KRW 36.1 billion at end-2025, all attributable to controlling shareholders, with total liabilities of KRW 15.9 billion, and the debt ratio fell from 63.4% in 2024 to 44.1% in 2025.
Operating cash flow was -KRW 11.2 billion in 2022, -KRW 12.1 billion in 2023, -KRW 10.1 billion in 2024 and -KRW 5.3 billion in 2025, with outflows in every year and the 2025 outflow the smallest.
Quarterly revenue was KRW 10.5 billion in Q3 2025, KRW 12.1 billion in Q4 2025 (up 14.7% from the prior quarter) and KRW 15.2 billion in Q1 2026 (up 26.1%), then fell to KRW 12 billion in Q2 2026 (down 21.3%) and KRW 10.4 billion in Q3 2026 (down 13.1% quarter on quarter and down 1.2% year on year), a two-quarter decline.
Operating losses have run for five consecutive quarters since Q3 2025, when the loss was KRW 940 million, reaching KRW 1.48 billion in Q1 2026 before narrowing to KRW 986 million in Q2 and KRW 560 million in Q3 2026.
Net income attributable to controlling shareholders was KRW 936 million in Q3 2025 and KRW 804 million in Q4 2025, then turned into a net loss of KRW 1.83 billion in Q1 2026, KRW 3.94 billion in Q2 and KRW 719 million in Q3, a three-quarter losing streak. The last four quarters total a net loss of KRW 5.69 billion attributable to controlling shareholders.